News
14 Jul 2021
A Word with Flamma
A short article that features Kenneth Drew, VP Flamma USA discussing what makes Flamma different from other CDMOs.
Flamma SpA, has a long history of dealing with high value chiral materials such as amino acid derivatives. How is this seen from innovator companies developing traditional small molecule #APIs and/or peptide drugs? If
your small molecule has a chiral piece within its structure, you should
be speaking with Flamma. In fact, other competitors within the #CDMO space often contact us to see if Flamma can make the necessary intermediate or RSM for them.
READ MORE & DOWNLOAD PDF: https://lnkd.in/dqiXD5P
Mentioned Companies
Flamma
